Hannah A. Blair

Hannah A. Blair

Mairangi Bay, AUK 0754, New Zealand

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 147 publications

Andamertinib: First Approval.

Andamertinib: First Approval.

Journal: Drugs
Published: July 12, 2026

Baxdrostat: First Approval.

Baxdrostat: First Approval.

Journal: Drugs
Published: June 29, 2026

Relacorilant: First Approval.

Relacorilant: First Approval.

Journal: Drugs
Published: May 12, 2026

Rovadicitinib: First Approval.

Rovadicitinib: First Approval.

Journal: Drugs
Published: April 27, 2026

Correction: Avutometinib and Defactinib: First Approval.

Correction: Avutometinib and Defactinib: First Approval.

Journal: Drugs
Published: April 09, 2026

Sonrotoclax: First Approval.

Sonrotoclax: First Approval.

Journal: Drugs
Published: March 24, 2026

Lerodalcibep: First Approval.

Lerodalcibep: First Approval.

Journal: Drugs
Published: March 10, 2026

Copper Histidinate: Pediatric First Approval.

Copper Histidinate: Pediatric First Approval.

Journal: Paediatric drugs
Published: March 04, 2026

Lenacapavir: A Review in HIV Pre-Exposure Prophylaxis.

Lenacapavir: A Review in HIV Pre-Exposure Prophylaxis.

Journal: Drugs
Published: March 01, 2026

Etuvetidigene Autotemcel: First Approval.

Etuvetidigene Autotemcel: First Approval.

Journal: Molecular diagnosis & therapy
Published: January 20, 2026

Correction: Bumetanide Nasal Spray: First Approval.

Correction: Bumetanide Nasal Spray: First Approval.

Journal: Clinical drug investigation
Published: January 19, 2026

Becotatug Vedotin: First Approval.

Becotatug Vedotin: First Approval.

Journal: Drugs
Published: December 15, 2025
Showing 1-12 of 147

Last Updated: 09/26/2026